Transcripts Defining MMU10 Conserved Linkages with HSA19, 21, and 22
| Mouse locus name | Human locus name and aliases | Genbank accession number | Gene name | Human location |
| Slc1a6[iv] | SLC1A6, EAAT4 | D83262 [ii] | Solute carrier family 1, member 6 | 19p13.1 |
| Aasl1[iv] | AASSL1, 209L8 | AI156588 [iii] | Human homolog of acetolactate synthetase like gene | 19p13.1 |
| D10Jhu34e[iv] | No known human orthologs | AI613583 [iii] | Mouse EST 851439 | (19 or 21)[v] |
| Pdxk[iv] | PDXK | AI529482 [ii] | Pyridoxal kinase | 21q22.3 |
| Cstb | CSTB, STFB | Cystatin B | 21q22.3 | |
| Nnp1 | NNP-1, D21S2056E | Novel nuclear protein 1 | 21q22.3 | |
| D10Jhu12e | Homology to human genomic sequence from 21q22.3 region | Mouse EST 515094 | 21q22.3 | |
| Tmem1 | TMEM1 | Transmembrane protein 1 | 21q22.3 | |
| Pwp2h[iv] | PWP2H | H50886 [ii] | Yeast periodic tryptophan protein 2 homolog | 21q22.3 |
| D10Jhu81e[iv] | D21S2048E, GT335, HES1, hES1, KNP-Ia, KNP-Ib | AA510875 [ii] | Homolog of ES1 | 21q22.3 |
| Aire1 | AIRE, APECED, APS1, PGA I | Autoimmune polyendocrinopathy syndrome, type I | 21q22.3 | |
| D10Jhu13e | C21ORF2 | mRNA mapping to APECED disease region (HSA 21q22.3) | 21q22.3 | |
| Pfkl | PFKL, PFK | Phosphofructokinase, liver type | 21q22.3 | |
| Trrp7[iv] | TRPC7 | NM003307[iii] | Transient receptor potential-related channel 7 | 21q22.3 |
| Krtap12-1 | KRTAP12-1 | High-cysteine keratin associated protein | 21q22.3 | |
| Ube2g2[iv] | UBE2G2, UBC7 | AA759396 [ii] | Ubiquitin-conjugating enzyme E2G 2 | 21q22.3 |
| Smt3h1 | SMT3H1, SMT3A, SMT3 | Supressor of mif two, 3 homolog 1 | 21q22.3 | |
| Itgb2 | ITGB2, CD18 | Integrin, beta-2 | 21q22.3 | |
| Adarb1 | ADARB1, RED1 | Adenosine deaminase, RNA-specific, B1 | 21q22.3 | |
| Col18a1 | COL18A1 | Collagen, type XVIII, alpha-1 | 21q22.3 | |
| Slc19a1 | SLC19A1, FOLT, RFC1, IFC1 | Solute carrier family 19, member 1 | 21q22.3 | |
| Col6a1 | COL6A1 | Collagen, type VI, alpha-1 | 21q22.3 | |
| Col6a2 | COL6A2 | Collagen, type VI, alpha-2 | 21q22.3 | |
| Lss | LSS, OSC | Lanosterol synthase | 21q22.3 | |
| D10Jhu64e[iv] | No known human orthologs | AA727480 [iii] | Mouse EST 1210378 | (21q22.3)[v] |
| S100b | S100B | S100 calcium-binding protein, beta | 21q22.3 | |
| Prmt2 | PRMT2, HRMT1L1 | hnRNP methyltransferase-1-like 1 | 21q22.3 | |
| Mmp11 | MMP11, STMY3 | matrix metalloproteinase 11 | 22q11.2 | |
| Mif | MIF | Macrophage migration inhibitory factor | 22q11.2 | |
| Gstt1 | GSTT1 | Glutathione S-transferase, theta 1 | 22q11.2 | |
| Ddt | DDT | D-dopachrome tautomerase | 22q11.2 | |
| Ppp3in[iv] | PPP3IN,KIAA0330 | AB002328 [iii] | Protein phosphatase 3 inhibitor | 22q11–12 |
| D10Jhu71e[iv] | No known human orthologs | AI615712 [iii] | Mouse EST 974977 | (22q12)[v] |
| Ggt2[iv] | GGT2 | U30509 [ii] | Gamma-glutamyl transpeptidase | 22q12 |
[i] Human map positions are from OMIM, GDB, and this analysis. Genes/ESTs are listed in the order that they appear on MMU10, telomeric to centromeric.
[ii] Accession number of sequence that was used to map the gene.
[iii] accession number of the EST/gene that was discovered from PAC end-sequence homology searches.
[iv] transcripts mapped for the first time in mouse.
[v] predicted location in human.